Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure.
Hurle R, Contieri R, Casale P, Morenghi E, Saita A, Buffi N, Lughezzani G, Colombo P, Frego N, Fasulo V, Paciotti M, Guazzoni G, Lazzeri M. Hurle R, et al. Among authors: contieri r. Urol Oncol. 2021 Mar;39(3):195.e7-195.e13. doi: 10.1016/j.urolonc.2020.09.017. Epub 2020 Oct 23. Urol Oncol. 2021. PMID: 33268275
Editorial Comment.
Hurle R, Contieri R, Lazzeri M. Hurle R, et al. Among authors: contieri r. J Urol. 2021 Jul;206(1):27. doi: 10.1097/JU.0000000000001689.01. Epub 2021 Apr 9. J Urol. 2021. PMID: 33835847 No abstract available.
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience.
Contieri R, Paciotti M, Lughezzani G, Buffi NM, Frego N, Diana P, Fasulo V, Saita A, Casale P, Lazzeri M, Guazzoni G, Hurle R. Contieri R, et al. Eur Urol Oncol. 2022 Apr;5(2):251-255. doi: 10.1016/j.euo.2021.05.002. Epub 2021 May 28. Eur Urol Oncol. 2022. PMID: 34059485
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience.
Paciotti M, Casale P, Colombo P, Fasulo V, Saita A, Lughezzani G, Contieri R, Buffi NM, Lazzeri M, Guazzoni G, Hurle R. Paciotti M, et al. Among authors: contieri r. Eur Urol Open Sci. 2021 Feb 24;26:64-71. doi: 10.1016/j.euros.2021.01.015. eCollection 2021 Apr. Eur Urol Open Sci. 2021. PMID: 34337509 Free PMC article.
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic?
Paciotti M, Contieri R, Fasulo V, Casale P, Saita A, Buffi NM, Lughezzani G, Diana P, Frego N, Guazzoni G, Lazzeri M, Hurle R. Paciotti M, et al. Among authors: contieri r. Minerva Urol Nephrol. 2022 Feb;74(1):1-4. doi: 10.23736/S2724-6051.21.04613-9. Epub 2021 Aug 2. Minerva Urol Nephrol. 2022. PMID: 34338493 Free article. No abstract available.
Combination of AST to ALT and neutrophils to lymphocytes ratios as predictors of locally advanced disease in patients with bladder cancer subjected to radical cystectomy: Results from a single-institutional series.
Uleri A, Hurle R, Contieri R, Diana P, Buffi N, Lazzeri M, Saita A, Casale P, Guazzoni G, Lughezzani G. Uleri A, et al. Among authors: contieri r. Urologia. 2022 Aug;89(3):363-370. doi: 10.1177/03915603211035191. Epub 2021 Aug 4. Urologia. 2022. PMID: 34346247
63 results